Genital herpes simplex virus infection

Clinical Obstetrics and Gynecology

Volumn 48, Issue 4, 2005, Pages 838-844

  Steben, Marc ^a,b  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; VALACICLOVIR;

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; GENITAL HERPES; HERPES VIRUS; HUMAN; LABORATORY TEST; PATIENT; RECURRENT DISEASE; REVIEW; SCREENING; SEROLOGY; STIGMA; VIRUS IDENTIFICATION; VIRUS INFECTION;

ANTIVIRAL AGENTS; FEMALE; HERPES GENITALIS; HUMANS; INFANT, NEWBORN; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RECURRENCE; TRUTH DISCLOSURE;

EID: 29544436690     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.grf.0000179634.87533.da     Document Type: Review

References (14)

1. Mertz GJ, Trees D, Levine WC, et al. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J Infect Dis. 1998;178:1795-1798.
2. Corey L, Wald A, Celum CL, et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004;35:435-445.
3. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med. 1994; 121:847-854.
4. Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med. 1992;116:197-202.
5. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States 1976 to 1994. N Engl J Med. 1997;337:1105-1111.
6. Corey L, Adams HG, Brown ZA, et al. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983;98:958-972.
7. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep. 2002;51:1-78.
8. Steben M. Practical considerations in diagnosing HSV infections in the clinic (International Herpes Management Forum web site). Available at: http://www.ihmf.org/library/down_k8_31.asp. Accessed February 28, 2004.
9. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004;350:11-20.
10. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med. 2002;347:1652-1661.
11. Clarke P. The impact of a herpes diagnosis and the implications for patient counselling. In: Sacks SL, Whitley RJ, Griffiths, eds. Clinical Management of Herpes Viruses. Burke: IOS Press; 1995:75-86.
12. Fortenberry JD. The effects of stigma on genital herpes care-seeking behaviours. Herpes. 2004;11:8-11.
13. Practice Bulletin No ACOG.8. Management of herpes in pregnancy, October 1999. Int J Gynaecol Obstet. 2000;68:165-173.
14. Practice Bulletin No ACOG57. Gynecologic herpes simplex virus infections. Obstet Gynecol. 2004;104:1111-1117.